Measurement of somatic neuropathy for clinical practice and clinical trials Vern A. La ScottSolomon Tesfaye OriginalPaper Pages: 208 - 215
Classification of wounds of the diabetic foot David G. ArmstrongEdgar J. G. Peters OriginalPaper Pages: 233 - 238
Potential gene transfer treatment for ischemic neuropathy Andrew J. M. Boulton Clinical Trials Report Pages: 239 - 239
The meaning of microalbuminuria in type 1 diabetes: The need for a new paradigm Sharon G. AdlerCynthia C. Nast Clinical Trials Report Pages: 241 - 244
Risk predictors in patients with diabetic nephropathy Paola FiorettoMaria Luiza CaramoriMichael Mauer OriginalPaper Pages: 245 - 250
Treatment of hypertension in diabetic patients with nephropathy Radko KomersSharon Anderson OriginalPaper Pages: 251 - 260
C-peptide: A new potential in the treatment of diabetic nephropathy John WahrenKarin EkbergBo-Lennart Johansson OriginalPaper Pages: 261 - 266
Angiotensin receptor blockers in diabetic nephropathy Deborah A. PriceNorman K. Hollenberg OriginalPaper Pages: 267 - 274
Genetics of diabetic nephropathy in the pima indians Giuseppina ImperatoreWilliam C. KnowlerRobert L. Hanson OriginalPaper Pages: 275 - 281
Oxidative stress in diabetic nephropathy: Basic and clinical information Hunjoo HaHi Bahl Lee OriginalPaper Pages: 282 - 287